1 Market Overview

1.1 Product Overview and Scope of Chronic Heart Failure Treatment

1.2 Classification of Chronic Heart Failure Treatment by Type

1.2.1 Overview: Global Chronic Heart Failure Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Chronic Heart Failure Treatment Revenue Market Share by Type in 2020

1.2.3 ICDs

1.2.4 VADs

1.2.5 Drugs

1.2.6 Others

1.3 Global Chronic Heart Failure Treatment Market by Application

1.3.1 Overview: Global Chronic Heart Failure Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.3.5 Others

1.4 Global Chronic Heart Failure Treatment Market Size & Forecast

1.5 Global Chronic Heart Failure Treatment Market Size and Forecast by Region

1.5.1 Global Chronic Heart Failure Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Chronic Heart Failure Treatment Market Size by Region, (2016-2021)

1.5.3 North America Chronic Heart Failure Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Chronic Heart Failure Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Chronic Heart Failure Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Chronic Heart Failure Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Chronic Heart Failure Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Chronic Heart Failure Treatment Market Drivers

1.6.2 Chronic Heart Failure Treatment Market Restraints

1.6.3 Chronic Heart Failure Treatment Trends Analysis

2 Company Profiles

2.1 Medtronic

2.1.1 Medtronic Details

2.1.2 Medtronic Major Business

2.1.3 Medtronic Chronic Heart Failure Treatment Product and Solutions

2.1.4 Medtronic Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Medtronic Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott Chronic Heart Failure Treatment Product and Solutions

2.2.4 Abbott Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Chronic Heart Failure Treatment Product and Solutions

2.3.4 Johnson & Johnson Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Johnson & Johnson Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Chronic Heart Failure Treatment Product and Solutions

2.4.4 Merck Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Stanley Pharmaceuticals

2.5.1 Stanley Pharmaceuticals Details

2.5.2 Stanley Pharmaceuticals Major Business

2.5.3 Stanley Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions

2.5.4 Stanley Pharmaceuticals Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Stanley Pharmaceuticals Recent Developments and Future Plans

2.6 New Haven Pharmaceuticals, Inc.

2.6.1 New Haven Pharmaceuticals, Inc. Details

2.6.2 New Haven Pharmaceuticals, Inc. Major Business

2.6.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product and Solutions

2.6.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 New Haven Pharmaceuticals, Inc. Recent Developments and Future Plans

2.7 Boston Scientific Corporation

2.7.1 Boston Scientific Corporation Details

2.7.2 Boston Scientific Corporation Major Business

2.7.3 Boston Scientific Corporation Chronic Heart Failure Treatment Product and Solutions

2.7.4 Boston Scientific Corporation Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Boston Scientific Corporation Recent Developments and Future Plans

2.8 HeartWare

2.8.1 HeartWare Details

2.8.2 HeartWare Major Business

2.8.3 HeartWare Chronic Heart Failure Treatment Product and Solutions

2.8.4 HeartWare Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 HeartWare Recent Developments and Future Plans

2.9 Pfizer

2.9.1 Pfizer Details

2.9.2 Pfizer Major Business

2.9.3 Pfizer Chronic Heart Failure Treatment Product and Solutions

2.9.4 Pfizer Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Pfizer Recent Developments and Future Plans

2.10 GlaxoSmithKline plc

2.10.1 GlaxoSmithKline plc Details

2.10.2 GlaxoSmithKline plc Major Business

2.10.3 GlaxoSmithKline plc Chronic Heart Failure Treatment Product and Solutions

2.10.4 GlaxoSmithKline plc Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.11 Novartis International AG

2.11.1 Novartis International AG Details

2.11.2 Novartis International AG Major Business

2.11.3 Novartis International AG Chronic Heart Failure Treatment Product and Solutions

2.11.4 Novartis International AG Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Novartis International AG Recent Developments and Future Plans

2.12 Biovail Corporation

2.12.1 Biovail Corporation Details

2.12.2 Biovail Corporation Major Business

2.12.3 Biovail Corporation Chronic Heart Failure Treatment Product and Solutions

2.12.4 Biovail Corporation Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Biovail Corporation Recent Developments and Future Plans

2.13 Bristol-Myers Squibb Company

2.13.1 Bristol-Myers Squibb Company Details

2.13.2 Bristol-Myers Squibb Company Major Business

2.13.3 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product and Solutions

2.13.4 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Bristol-Myers Squibb Company Recent Developments and Future Plans

2.14 Abiomed

2.14.1 Abiomed Details

2.14.2 Abiomed Major Business

2.14.3 Abiomed Chronic Heart Failure Treatment Product and Solutions

2.14.4 Abiomed Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Abiomed Recent Developments and Future Plans

2.15 Symplmed Pharmaceuticals

2.15.1 Symplmed Pharmaceuticals Details

2.15.2 Symplmed Pharmaceuticals Major Business

2.15.3 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions

2.15.4 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Symplmed Pharmaceuticals Recent Developments and Future Plans

2.16 Berlin Heart GmbH

2.16.1 Berlin Heart GmbH Details

2.16.2 Berlin Heart GmbH Major Business

2.16.3 Berlin Heart GmbH Chronic Heart Failure Treatment Product and Solutions

2.16.4 Berlin Heart GmbH Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Berlin Heart GmbH Recent Developments and Future Plans

2.17 ReliantHeart, Inc.

2.17.1 ReliantHeart, Inc. Details

2.17.2 ReliantHeart, Inc. Major Business

2.17.3 ReliantHeart, Inc. Chronic Heart Failure Treatment Product and Solutions

2.17.4 ReliantHeart, Inc. Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 ReliantHeart, Inc. Recent Developments and Future Plans

2.18 Cardiokinetix

2.18.1 Cardiokinetix Details

2.18.2 Cardiokinetix Major Business

2.18.3 Cardiokinetix Chronic Heart Failure Treatment Product and Solutions

2.18.4 Cardiokinetix Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Cardiokinetix Recent Developments and Future Plans

2.19 Biotronik

2.19.1 Biotronik Details

2.19.2 Biotronik Major Business

2.19.3 Biotronik Chronic Heart Failure Treatment Product and Solutions

2.19.4 Biotronik Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Biotronik Recent Developments and Future Plans

2.20 Jarvik Heart

2.20.1 Jarvik Heart Details

2.20.2 Jarvik Heart Major Business

2.20.3 Jarvik Heart Chronic Heart Failure Treatment Product and Solutions

2.20.4 Jarvik Heart Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Jarvik Heart Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Chronic Heart Failure Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Chronic Heart Failure Treatment Players Market Share

3.2.2 Top 10 Chronic Heart Failure Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Chronic Heart Failure Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Chronic Heart Failure Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Chronic Heart Failure Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Chronic Heart Failure Treatment Revenue Market Share by Application (2016-2021)

5.2 Chronic Heart Failure Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Chronic Heart Failure Treatment Revenue by Type (2016-2026)

6.2 North America Chronic Heart Failure Treatment Revenue by Application (2016-2026)

6.3 North America Chronic Heart Failure Treatment Market Size by Country

6.3.1 North America Chronic Heart Failure Treatment Revenue by Country (2016-2026)

6.3.2 United States Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Chronic Heart Failure Treatment Revenue by Type (2016-2026)

7.2 Europe Chronic Heart Failure Treatment Revenue by Application (2016-2026)

7.3 Europe Chronic Heart Failure Treatment Market Size by Country

7.3.1 Europe Chronic Heart Failure Treatment Revenue by Country (2016-2026)

7.3.2 Germany Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

7.3.3 France Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Chronic Heart Failure Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Chronic Heart Failure Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region

8.3.1 Asia-Pacific Chronic Heart Failure Treatment Revenue by Region (2016-2026)

8.3.2 China Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8.3.5 India Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Chronic Heart Failure Treatment Revenue by Type (2016-2026)

9.2 South America Chronic Heart Failure Treatment Revenue by Application (2016-2026)

9.3 South America Chronic Heart Failure Treatment Market Size by Country

9.3.1 South America Chronic Heart Failure Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Chronic Heart Failure Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Chronic Heart Failure Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country

10.3.1 Middle East & Africa Chronic Heart Failure Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Chronic Heart Failure Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Chronic Heart Failure Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Chronic Heart Failure Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Chronic Heart Failure Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Chronic Heart Failure Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Chronic Heart Failure Treatment Revenue Market Share by Region (2021-2026)

Table 6. Medtronic Corporate Information, Head Office, and Major Competitors

Table 7. Medtronic Major Business

Table 8. Medtronic Chronic Heart Failure Treatment Product and Solutions

Table 9. Medtronic Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott Chronic Heart Failure Treatment Product and Solutions

Table 13. Abbott Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 15. Johnson & Johnson Major Business

Table 16. Johnson & Johnson Chronic Heart Failure Treatment Product and Solutions

Table 17. Johnson & Johnson Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Chronic Heart Failure Treatment Product and Solutions

Table 21. Merck Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Stanley Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Stanley Pharmaceuticals Major Business

Table 24. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions

Table 25. Stanley Pharmaceuticals Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. New Haven Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. New Haven Pharmaceuticals, Inc. Major Business

Table 28. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product and Solutions

Table 29. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors

Table 31. Boston Scientific Corporation Major Business

Table 32. Boston Scientific Corporation Chronic Heart Failure Treatment Product and Solutions

Table 33. Boston Scientific Corporation Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. HeartWare Corporate Information, Head Office, and Major Competitors

Table 35. HeartWare Major Business

Table 36. HeartWare Chronic Heart Failure Treatment Product and Solutions

Table 37. HeartWare Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Pfizer Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Major Business

Table 40. Pfizer Chronic Heart Failure Treatment Product and Solutions

Table 41. Pfizer Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 43. GlaxoSmithKline plc Major Business

Table 44. GlaxoSmithKline plc Chronic Heart Failure Treatment Product and Solutions

Table 45. GlaxoSmithKline plc Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Novartis International AG Corporate Information, Head Office, and Major Competitors

Table 47. Novartis International AG Major Business

Table 48. Novartis International AG Chronic Heart Failure Treatment Product and Solutions

Table 49. Novartis International AG Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Biovail Corporation Corporate Information, Head Office, and Major Competitors

Table 51. Biovail Corporation Major Business

Table 52. Biovail Corporation Chronic Heart Failure Treatment Product and Solutions

Table 53. Biovail Corporation Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors

Table 55. Bristol-Myers Squibb Company Major Business

Table 56. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product and Solutions

Table 57. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Abiomed Corporate Information, Head Office, and Major Competitors

Table 59. Abiomed Major Business

Table 60. Abiomed Chronic Heart Failure Treatment Product and Solutions

Table 61. Abiomed Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Symplmed Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. Symplmed Pharmaceuticals Major Business

Table 64. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions

Table 65. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Berlin Heart GmbH Corporate Information, Head Office, and Major Competitors

Table 67. Berlin Heart GmbH Major Business

Table 68. Berlin Heart GmbH Chronic Heart Failure Treatment Product and Solutions

Table 69. Berlin Heart GmbH Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. ReliantHeart, Inc. Corporate Information, Head Office, and Major Competitors

Table 71. ReliantHeart, Inc. Major Business

Table 72. ReliantHeart, Inc. Chronic Heart Failure Treatment Product and Solutions

Table 73. ReliantHeart, Inc. Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Cardiokinetix Corporate Information, Head Office, and Major Competitors

Table 75. Cardiokinetix Major Business

Table 76. Cardiokinetix Chronic Heart Failure Treatment Product and Solutions

Table 77. Cardiokinetix Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Biotronik Corporate Information, Head Office, and Major Competitors

Table 79. Biotronik Major Business

Table 80. Biotronik Chronic Heart Failure Treatment Product and Solutions

Table 81. Biotronik Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Jarvik Heart Corporate Information, Head Office, and Major Competitors

Table 83. Jarvik Heart Major Business

Table 84. Jarvik Heart Chronic Heart Failure Treatment Product and Solutions

Table 85. Jarvik Heart Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Chronic Heart Failure Treatment Revenue (USD Million) by Players (2019-2021)

Table 87. Global Chronic Heart Failure Treatment Revenue Share by Players (2019-2021)

Table 88. Breakdown of Chronic Heart Failure Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Chronic Heart Failure Treatment Players Head Office, Products and Services Provided

Table 90. Chronic Heart Failure Treatment Mergers & Acquisitions in the Past Five Years

Table 91. Chronic Heart Failure Treatment New Entrants and Expansion Plans

Table 92. Global Chronic Heart Failure Treatment Revenue (USD Million) by Type (2016-2021)

Table 93. Global Chronic Heart Failure Treatment Revenue Share by Type (2016-2021)

Table 94. Global Chronic Heart Failure Treatment Revenue Forecast by Type (2021-2026)

Table 95. Global Chronic Heart Failure Treatment Revenue by Application (2016-2021)

Table 96. Global Chronic Heart Failure Treatment Revenue Forecast by Application (2021-2026)

Table 97. North America Chronic Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Chronic Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Chronic Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Chronic Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Chronic Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Chronic Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Chronic Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Chronic Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Chronic Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Chronic Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Chronic Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Chronic Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Chronic Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Chronic Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Chronic Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Chronic Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Chronic Heart Failure Treatment Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Chronic Heart Failure Treatment Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Chronic Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Chronic Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Chronic Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Chronic Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Chronic Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Chronic Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Chronic Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Chronic Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Chronic Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Chronic Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Chronic Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Chronic Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Chronic Heart Failure Treatment Picture

Figure 2. Global Chronic Heart Failure Treatment Revenue Market Share by Type in 2020

Figure 3. ICDs

Figure 4. VADs

Figure 5. Drugs

Figure 6. Others

Figure 7. Chronic Heart Failure Treatment Revenue Market Share by Application in 2020

Figure 8. Hospital Picture

Figure 9. Clinic Picture

Figure 10. Household Picture

Figure 11. Others Picture

Figure 12. Global Chronic Heart Failure Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Chronic Heart Failure Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Chronic Heart Failure Treatment Revenue Market Share by Region (2016-2026)

Figure 15. Global Chronic Heart Failure Treatment Revenue Market Share by Region in 2020

Figure 16. North America Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Chronic Heart Failure Treatment Market Drivers

Figure 22. Chronic Heart Failure Treatment Market Restraints

Figure 23. Chronic Heart Failure Treatment Market Trends

Figure 24. Medtronic Recent Developments and Future Plans

Figure 25. Abbott Recent Developments and Future Plans

Figure 26. Johnson & Johnson Recent Developments and Future Plans

Figure 27. Merck Recent Developments and Future Plans

Figure 28. Stanley Pharmaceuticals Recent Developments and Future Plans

Figure 29. New Haven Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 30. Boston Scientific Corporation Recent Developments and Future Plans

Figure 31. HeartWare Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 34. Novartis International AG Recent Developments and Future Plans

Figure 35. Biovail Corporation Recent Developments and Future Plans

Figure 36. Bristol-Myers Squibb Company Recent Developments and Future Plans

Figure 37. Abiomed Recent Developments and Future Plans

Figure 38. Symplmed Pharmaceuticals Recent Developments and Future Plans

Figure 39. Berlin Heart GmbH Recent Developments and Future Plans

Figure 40. ReliantHeart, Inc. Recent Developments and Future Plans

Figure 41. Cardiokinetix Recent Developments and Future Plans

Figure 42. Biotronik Recent Developments and Future Plans

Figure 43. Jarvik Heart Recent Developments and Future Plans

Figure 44. Global Chronic Heart Failure Treatment Revenue Share by Players in 2020

Figure 45. Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 46. Global Top 3 Players Chronic Heart Failure Treatment Revenue Market Share in 2020

Figure 47. Global Top 10 Players Chronic Heart Failure Treatment Revenue Market Share in 2020

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 49. Global Chronic Heart Failure Treatment Revenue Share by Type in 2020

Figure 50. Global Chronic Heart Failure Treatment Market Share Forecast by Type (2021-2026)

Figure 51. Global Chronic Heart Failure Treatment Revenue Share by Application in 2020

Figure 52. Global Chronic Heart Failure Treatment Market Share Forecast by Application (2021-2026)

Figure 53. North America Chronic Heart Failure Treatment Sales Market Share by Type (2016-2026)

Figure 54. North America Chronic Heart Failure Treatment Sales Market Share by Application (2016-2026)

Figure 55. North America Chronic Heart Failure Treatment Revenue Market Share by Country (2016-2026)

Figure 56. United States Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Canada Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Mexico Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Europe Chronic Heart Failure Treatment Sales Market Share by Type (2016-2026)

Figure 60. Europe Chronic Heart Failure Treatment Sales Market Share by Application (2016-2026)

Figure 61. Europe Chronic Heart Failure Treatment Revenue Market Share by Country (2016-2026)

Figure 62. Germany Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. France Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. United Kingdom Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Russia Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Italy Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Asia-Pacific Chronic Heart Failure Treatment Sales Market Share by Type (2016-2026)

Figure 68. Asia-Pacific Chronic Heart Failure Treatment Sales Market Share by Application (2016-2026)

Figure 69. Asia-Pacific Chronic Heart Failure Treatment Revenue Market Share by Region (2016-2026)

Figure 70. China Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Japan Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South Korea Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. India Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Southeast Asia Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Australia Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South America Chronic Heart Failure Treatment Sales Market Share by Type (2016-2026)

Figure 77. South America Chronic Heart Failure Treatment Sales Market Share by Application (2016-2026)

Figure 78. South America Chronic Heart Failure Treatment Revenue Market Share by Country (2016-2026)

Figure 79. Brazil Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Argentina Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Middle East and Africa Chronic Heart Failure Treatment Sales Market Share by Type (2016-2026)

Figure 82. Middle East and Africa Chronic Heart Failure Treatment Sales Market Share by Application (2016-2026)

Figure 83. Middle East and Africa Chronic Heart Failure Treatment Revenue Market Share by Country (2016-2026)

Figure 84. Turkey Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Saudi Arabia Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. UAE Chronic Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source